Clinical Considerations in Dose Reduction and Adverse Effects for Ovarian Cancer Treatment
October 31st 2024With Martina Murphy, MD, collaborates with the Oncology Brothers to explore personalized treatment strategies for ovarian cancer, emphasizing dose reduction and the management of adverse effects to enhance patient care and outcomes.
Role of Adjuvant Chemotherapy in Early-Stage Endometrioid and Clear Cell Ovarian Cancer
October 31st 2024With Martina Murphy, MD, the Oncology Brothers discuss the role of adjuvant chemotherapy in early-stage endometrioid and clear cell ovarian cancer, highlighting its impact on improving patient outcomes and the importance of tailored treatment strategies.
Epithelial Ovarian/Fallopian Tube/Primary Peritoneal Cancer
October 31st 2024With Martina Murphy, MD, the Oncology Brothers discuss the latest advancements in the diagnosis and treatment of epithelial ovarian, fallopian tube, and primary peritoneal cancers, emphasizing the importance of a multidisciplinary approach for optimal patient outcomes.